| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | Faulkingham Dell | SVP, CCO | Feb 28, 2022 | Sale | $2.15 | 6,479 | 13,961 | 130,546 | Mar 02, 2022, 09:10 PM | |
| AKBA | Akebia Therapeutics, Inc. | Faulkingham Dell | SVP, CCO | Mar 01, 2022 | Sale | $2.17 | 6,705 | 14,555 | 174,798 | Mar 02, 2022, 09:10 PM | |
| AKBA | Akebia Therapeutics, Inc. | Faulkingham Dell | SVP, CCO | Apr 01, 2021 | Sale | $3.40 | 952 | 3,237 | 137,025 | Apr 01, 2021, 08:35 PM | |
| AKBA | Akebia Therapeutics, Inc. | Faulkingham Dell | CCO | Mar 01, 2021 | Sale | $3.40 | 6,749 | 22,920 | 128,825 | Mar 02, 2021, 04:08 PM | |
| AKBA | Akebia Therapeutics, Inc. | Faulkingham Dell | CCO | Jun 01, 2020 | Sale | $11.58 | 6,426 | 74,413 | 73,574 | Jun 02, 2020, 04:34 PM |
Menu